Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Polyrizon (PLRZ) announced the preliminary safety study for a formulation of its PL-14 Allergy Blocker. Conducted on fully differentiated human ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful ...

Scientists have developed oral nanorobots that target damaged heart tissue, deliver energy, and repair mitochondrial function ...

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

Seres Therapeutics, Inc.’s MCRB share price has surged by 2054.50%, which has investors questioning if this is right time to ...

A study published in the American Journal of Obstetrics & Gynecology by researchers at Baylor College of Medicine, UTHealth ...

A study published in the American Journal of Obstetrics & Gynecology by researchers at Baylor College of Medicine, UTHealth ...